Ghrelin Gene Products in Acute and Chronic Inflammation

Archivum Immunologiae et Therapiae Experimentalis

Volumn 62, Issue 5, 2014, Pages 369-384

  Prodam, Flavia ^a   Filigheddu, Nicoletta ^a  

^a UNIVERSITY OF EASTERN PIEDMONT   (Italy)

Author keywords

Acylated ghrelin; Autoimmune disease; Inflammatory disease; Obestatin; Unacylated ghrelin

Indexed keywords

GHRELIN; GROWTH HORMONE; MESSENGER RNA; OBESTATIN; PEPTIDE FRAGMENT;

ALZHEIMER DISEASE; ATHEROSCLEROSIS; ATROPHIC GASTRITIS; AUTOIMMUNE THYROIDITIS; AUTOIMMUNITY; CACHEXIA; CELIAC DISEASE; CHRONIC INFLAMMATION; CYSTIC FIBROSIS; GENE EXPRESSION; HORMONE RELEASE; HUMAN; INFLAMMATION; INFLAMMATORY BOWEL DISEASE; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHATIC SYSTEM; MULTIPLE SCLEROSIS; NONHUMAN; PROTEIN EXPRESSION; REVIEW; RHEUMATIC DISEASE; SEPSIS; UVEITIS; ANIMAL; AUTOIMMUNE DISEASE; CHRONIC DISEASE; GENETICS; IMMUNOLOGY; NEUROENDOCRINOLOGY; TRENDS;

ANIMALS; AUTOIMMUNE DISEASES; CHRONIC DISEASE; GHRELIN; HUMANS; INFLAMMATION; NEUROENDOCRINOLOGY; PEPTIDE FRAGMENTS;

EID: 84919842844     PISSN: 0004069X     EISSN: 16614917     Source Type: Journal    
DOI: 10.1007/s00005-014-0287-9     Document Type: Review

References (218)

1. Agnew AJ, Robinson E, McVicar CM et al (2012) The gastrointestinal peptide obestatin induces vascular relaxation via specific activation of endothelium-dependent NO signalling. Br J Pharmacol 166:327–338
2. Alexandridis E, Zisimopoulos A, Liratzopoulos N et al (2009) Obestatin/ghrelin ratio: a new activity index in inflammatory bowel diseases. Inflamm Bowel Dis 15:1557–1561
3. Alloatti G, Arnoletti E, Bassino E et al (2010) Obestatin affords cardioprotection to the ischemic-reperfused isolated rat heart and inhibits apoptosis in cultures of similarly stressed cardiomyocytes. Am J Physiol Heart Circ Physiol 299:H470–H481
4. Alonso N, Granada ML, Salinas I et al (2007) Plasma ghrelin concentrations in type 1 diabetic patients with autoimmune atrophic gastritis. Eur J Endocrinol 157:763–769
5. Altinova AE, Toruner F, Karakoc A et al (2006) Serum ghrelin levels in patients with Hashimoto’s thyroiditis. Thyroid 16:1259–1264
6. Anderwald-Stadler M, Krebs M, Promintzer M et al (2007) Plasma obestatin is lower at fasting and not suppressed by insulin in insulin-resistant humans. Am J Physiol Endocrinol Metab 293:E1393–E1398
7. Aragno M, Mastrocola R, Ghé C et al (2012) Obestatin induced recovery of myocardial dysfunction in type 1 diabetic rats: underlying mechanisms. Cardiovasc Diabetol 11:129
8. Argilés JM, Stemmler B (2013) The potential of ghrelin in the treatment of cancer cachexia. Expert Opin Biol Ther 13:67–76
9. Ariyasu H, Takaya K, Tagami T et al (2001) Stomach is a major source of circulating ghrelin, and feeding state determines plasma ghrelin-like immunoreactivity levels in humans. J Clin Endocrinol Metab 86:4753–4758
10. Asakawa A, Inui A, Fujimiya M et al (2005) Stomach regulates energy balance via acylated ghrelin and desacyl ghrelin. Gut 54:18–24
11. Ashraf A, Mick G, Meleth S et al (2007) Insulin treatment reduces pre-prandial plasma ghrelin concentrations in children with type 1 diabetes. Med Sci Monit 13:CR533–CR537
12. Ates Y, Degertekin B, Erdil A et al (2008) Serum ghrelin levels in inflammatory bowel disease with relation to disease activity and nutritional status. Dig Dis Sci 53:2215–2221
13. Azevedo-Pinto S, Pereira-Silva P, Rocha-Sousa A (2013) Ghrelin in ocular pathophysiology: from the anterior to the posterior segment. Peptides 47:12–19
14. Baatar D, Patel K, Taub DD (2011) The effects of ghrelin on inflammation and the immune system. Mol Cell Endocrinol 340:44–58
15. Balasubramaniam A, Wood S, Joshi R et al (2006) Ghrelin stimulates food intake and growth hormone release in rats with thermal injury: synthesis of ghrelin. Peptides 27:1624–1631
16. Baldanzi G, Filigheddu N, Cutrupi S et al (2002) Ghrelin and des-acyl ghrelin inhibit cell death in cardiomyocytes and endothelial cells through ERK1/2 and PI 3-kinase/AKT. J Cell Biol 159:1029–1037
17. Bando M, Iwakura H, Ariyasu H et al (2013) Overexpression of intraislet ghrelin enhances β-cell proliferation after streptozotocin-induced β-cell injury in mice. Am J Physiol Endocrinol Metab 305:E140–E148
18. Bansal V, Ryu SY, Lopez N et al (2012) Vagal stimulation modulates inflammation through a ghrelin mediated mechanism in traumatic brain injury. Inflammation 35:214–220
19. Baragli A, Grande C, Gesmundo I et al (2013) Obestatin enhances in vitro generation of pancreatic islets through regulation of developmental pathways. PLoS ONE 8:e64374
20. Barazzoni R, Semolic A, Cattin MR et al (2014) Acylated ghrelin limits fat accumulation and improves redox state and inflammation markers in the liver of high-fat-fed rats. Obesity 22:170–177
21. Bassil AK, Häglund Y, Brown J et al (2007) Little or no ability of obestatin to interact with ghrelin or modify motility in the rat gastrointestinal tract. Br J Pharmacol 150:58–64
22. Beck B, Pourié G (2013) Ghrelin, neuropeptide Y, and other feeding-regulatory peptides active in the hippocampus: role in learning and memory. Nutr Rev 71:541–561
23. Bednarek MA, Feighner SD, Pong SS et al (2000) Structure-function studies on the new growth hormone-releasing peptide, ghrelin: minimal sequence of ghrelin necessary for activation of growth hormone secretagogue receptor 1a. J Med Chem 43:4370–4376
24. Benso A, Prodam F, Lucatello B et al (2007) d-Lys-GHRP-6 does not modify the endocrine response to acylated ghrelin or hexarelin in humans. Neuropeptides 41:45–49
25. Benso A, St-Pierre DH, Prodam F et al (2012) Metabolic effects of overnight continuous infusion of unacylated ghrelin in humans. Eur J Endocrinol 166:911–916
26. Berilgen MS, Bulut S, Ustundag B et al (2005) Patients with multiple sclerosis have higher levels of serum ghrelin. Neuro Endocrinol Lett 26:819–822
27. Bideci A, Camurdan MO, Cinaz P et al (2005) Ghrelin, IGF-I and IGFBP-3 levels in children with type 1 diabetes mellitus. J Pediatr Endocrinol Metab 18:1433–1499
28. Bossowski A, Czarnocka B, Harasymczuk J et al (2013) Identification of GPR39 receptor and ghrelin receptor in thyroid tissues in paediatric patients with immune and non-immune thyroid diseases. Horm Res Paediatr 79:130–136
29. Broglio F, Gottero C, Prodam F et al (2004) Non-acylated ghrelin counteracts the metabolic but not the neuroendocrine response to acylated ghrelin in humans. J Clin Endocrinol Metab 89:3062–3065
30. Broglio F, Prodam F, Riganti F et al (2008) The continuous infusion of acylated ghrelin enhances growth hormone secretion and worsens glucose metabolism in humans. J Endocrinol Invest 31:788–794
31. Bulgarelli I, Tamiazzo L, Bresciani E et al (2009) Desacyl-ghrelin and synthetic GH-secretagogues modulate the production of inflammatory cytokines in mouse microglia cells stimulated by beta-amyloid fibrils. J Neurosci Res 87:2718–2727
32. Capristo E, Farnetti S, Mingrone G et al (2005) Reduced plasma ghrelin concentration in celiac disease after gluten-free diet treatment. Scand J Gastroenterol 40:430–436
33. Cassoni P, Papotti M, Ghè C et al (2001) Identification, characterization, and biological activity of specific receptors for natural (ghrelin) and synthetic growth hormone secretagogues and analogs in human breast carcinomas and cell lines. J Clin Endocrinol Metab 86:1738–1745
34. Cassoni P, Ghé C, Marrocco T et al (2004) Expression of ghrelin and biological activity of specific receptors for ghrelin and des-acyl ghrelin in human prostate neoplasms and related cell lines. Eur J Endocrinol 150:173–184
35. Celi F, Bini V, Papi F et al (2005) Circulating acylated and total ghrelin and galanin in children with insulin-treated type 1 diabetes: relationship to insulin therapy, metabolic control and pubertal development. Clin Endocrinol 63:139–145
36. Chang L, Du JB, Gao LR et al (2003a) Effect of ghrelin on septic shock in rats. Acta Pharmacol Sin 24:45–49
37. Chang L, Zhao J, Yang J et al (2003b) Therapeutic effects of ghrelin on endotoxic shock in rats. Eur J Pharmacol 473:171–176
38. Chartrel N, Alvear-Perez R, Leprince J et al (2007) Comment on “Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin’s effects on food intake”. Science 315:766
39. Checchi S, Montanaro A, Pasqui L et al (2007) Serum ghrelin as a marker of atrophic body gastritis in patients with parietal cell antibodies. J Clin Endocrinol Metab 92:4346–4351
40. Chen CY, Tsai CY (2012) Ghrelin and motilin in the gastrointestinal system. Curr Pharm Des 18:4755–4765
41. Chen Y, Cao CP, Li CR et al (2010) Ghrelin modulates insulin sensitivity and tau phosphorylation in high glucose-induced hippocampal neurons. Biol Pharm Bull 33:1165–1169
42. Chen CY, Tsai CY, Lee PC et al (2013) Long-term etanercept therapy favors weight gain and ameliorates cachexia in rheumatoid arthritis patients: roles of gut hormones and leptin. Curr Pharm Des 19:1956–1964
43. Cheng B, Wan J, Wang Y et al (2010) Ghrelin inhibits foam cell formation via simultaneously down-regulating the expression of acyl-coenzyme A: cholesterol acyltransferase 1 and up-regulating adenosine triphosphate-binding cassette transporter A1. Cardiovasc Pathol 19:e159–e166
44. Cheyuo C, Wu R, Zhou M et al (2011) Ghrelin suppresses inflammation and neuronal nitric oxide synthase in focal cerebral ischemia via the vagus nerve. Shock 35:258–265
45. Chorny A, Anderson P, Gonzalez-Rey E et al (2008) Ghrelin protects against experimental sepsis by inhibiting high-mobility group box 1 release and by killing bacteria. J Immunol 180:8369–8377
46. Chung H, Seo S, Moon M et al (2008) Phosphatidylinositol-3-kinase/Akt/glycogen synthase kinase-3 beta and ERK1/2 pathways mediate protective effects of acylated and unacylated ghrelin against oxygen-glucose deprivation-induced apoptosis in primary rat cortical neuronal cells. J Endocrinol 198:511–521
47. Cohen RI, Tsang D, Koenig S et al (2008) Plasma ghrelin and leptin in adult cystic fibrosis patients. J Cyst Fibros 7:398–402
48. Cohen RI, Chandra S, Koenig S et al (2010) Ghrelin receptor expression in lymphocytes isolated from adult cystic fibrosis patients. Respiration 79:141–146
49. Coskun ZM, Sacan O, Karatug A et al (2013) Regulation of oxidative stress and somatostatin, cholecystokinin, apelin gene expressions by ghrelin in stomach of newborn diabetic rats. Acta Histochem 115:740–747
50. Cui AD, Gai NN, Zhang XH et al (2012) Decreased serum obestatin consequent upon TRIB3 Q84R polymorphism exacerbates carotid atherosclerosis in subjects with metabolic syndrome. Diabetol Metab Syndr 4:52
51. Cummings DE (2006) Ghrelin and the short- and long-term regulation of appetite and body weight. Physiol Behav 89:71–84
52. Cummings DE, Clement K, Purnell JQ et al (2002) Elevated plasma ghrelin levels in Prader Willi syndrome. Nat Med 8:643–644
53. de Lecea L, Castaño JP (2006) Cortistatin: not just another somatostatin analog. Nat Clin Pract Endocrinol Metab 2:356–357
54. De Smet B, Thijs T, Moechars D et al (2009) Endogenous and exogenous ghrelin enhance the colonic and gastric manifestations of dextran sodium sulphate-induced colitis in mice. Neurogastroenterol Motil 21:59–70
55. DeBoer MD, Zhu XX, Levasseur P et al (2007) Ghrelin treatment causes increased food intake and retention of lean body mass in a rat model of cancer cachexia. Endocrinology 148:3004–3012
56. DeBoer MD, Zhu X, Levasseur PR et al (2008) Ghrelin treatment of chronic kidney disease: improvements in lean body mass and cytokine profile. Endocrinology 149:827–835
57. Delgado M, Ganea D (2008) Anti-inflammatory neuropeptides: a new class of endogenous immunoregulatory agents. Brain Behav Immun 22:1146–1151
58. Delhanty PJ, van der Eerden BC, van der Velde M et al (2006) Ghrelin and unacylated ghrelin stimulate human osteoblast growth via mitogen-activated protein kinase (MAPK)/phosphoinositide 3-kinase (PI3K) pathways in the absence of GHSR-1a. J Endocrinol 188:37–47
59. Delhanty PJ, van Koetsveld PM, Gauna C et al (2007) Ghrelin and its unacylated isoform stimulate the growth of adrenocortical tumor cells via an anti-apoptotic pathway. Am J Physiol Endocrinol Metab 293:E302–E309
60. Delhanty PJ, Huisman M, Baldeon-Rojas LY et al (2013) Des-acyl ghrelin analogs prevent high-fat-diet-induced dysregulation of glucose homeostasis. FASEB J 27:1690–1700
61. Demers A, McNicoll N, Febbraio M et al (2004) Identification of the growth hormone-releasing peptide binding site in CD36: a photoaffinity cross-linking study. Biochem J 382:417–424
62. Demers A, Caron V, Rodrigue-Way A et al (2009) A concerted kinase interplay identifies PPARgamma as a molecular target of ghrelin signaling in macrophages. PLoS ONE 4:e7728
63. Depoortere I, Thijs T, Peeters T (2006) The contractile effect of the ghrelin receptor antagonist, d-Lys3-GHRP-6, in rat fundic strips is mediated through 5-HT receptors. Eur J Pharmacol 537:160–165
64. Dhurandhar EJ, Allison DB, van Groen T et al (2013) Hunger in the absence of caloric restriction improves cognition and attenuates Alzheimer’s disease pathology in a mouse model. PLoS ONE 8:e60437
65. Dixit VD, Schaffer EM, Pyle RS et al (2004) Ghrelin inhibits leptin- and activation-induced proinflammatory cytokine expression by human monocytes and T cells. J Clin Invest 114:57–66
66. Doi A, Shono T, Nishi M et al (2006) IA-2beta, but not IA-2, is induced by ghrelin and inhibits glucose-stimulated insulin secretion. Proc Natl Acad Sci USA 103:885–890
67. Dong J, Peeters TL, De Smet B et al (2006) Role of endogenous ghrelin in the hyperphagia of mice with streptozotocin-induced diabetes. Endocrinology 147:2634–2642
68. Egido EM, Hernández R, Marco J et al (2009) Effect of obestatin on insulin, glucagon and somatostatin secretion in the perfused rat pancreas. Regul Pept 152:61–66
69. El Eter E, Al Tuwaijiri A, Hagar H et al (2007) In vivo and in vitro antioxidant activity of ghrelin: attenuation of gastric ischemic injury in the rat. J Gastroenterol Hepatol 22:1791–1799
70. Erriquez J, Bernascone S, Ciarletta M et al (2009) Calcium signals activated by ghrelin and d-Lys(3)-GHRP-6 ghrelin antagonist in developing dorsal root ganglion glial cells. Cell Calcium 46:197–208
71. Favaro E, Granata R, Miceli I et al (2012) The ghrelin gene products and exendin-4 promote survival of human pancreatic islet endothelial cells in hyperglycaemic conditions, through phosphoinositide 3-kinase/Akt, extracellular signal-related kinase (ERK)1/2 and cAMP/protein kinase A (PKA) signalling pathways. Diabetologia 55:1058–1070
72. Filigheddu N, Gnocchi VF, Coscia M et al (2007) Ghrelin and des-acyl ghrelin promote differentiation and fusion of C2C12 skeletal muscle cells. Mol Biol Cell 18:986–994
73. Gahete MD, Rubio A, Córdoba-Chacón J et al (2010) Expression of the ghrelin and neurotensin systems is altered in the temporal lobe of Alzheimer’s disease patients. J Alzheimers Dis 22:819–828
74. Gao M, Yang J, Liu G et al (2012) Ghrelin promotes the differentiation of human embryonic stem cells in infarcted cardiac microenvironment. Peptides 34:373–379
75. Gao M, Yang J, Wei R et al (2013) Ghrelin induces cardiac lineage differentiation of human embryonic stem cells through ERK1/2 pathway. Int J Cardiol 167:2724–2733
76. Garcia JM, Garcia-Touza M, Hijazi RA et al (2005) Active ghrelin levels and active to total ghrelin ratio in cancer-induced cachexia. J Clin Endocrinol Metab 90:2920–2926
77. García-García F, Juárez-Aguilar E, Santiago-García J et al (2014) Ghrelin and its interactions with growth hormone, leptin and orexins: implications for the sleep-wake cycle and metabolism. Sleep Med Rev 18:89–97
78. Gauna C, Delhanty PJ, Hofland LJ et al (2005) Ghrelin stimulates, whereas des-octanoyl ghrelin inhibits, glucose output by primary hepatocytes. J Clin Endocrinol Metab 90:1055–1060
79. Gauna C, van de Zande B, van Kerkwijk A et al (2007) Unacylated ghrelin is not a functional antagonist but a full agonist of the type 1a growth hormone secretagogue receptor (GHS-R). Mol Cell Endocrinol 274:30–34
80. Gelling RW, Overduin J, Morrison CD et al (2004) Effect of uncontrolled diabetes on plasma ghrelin concentrations and ghrelin-induced feeding. Endocrinology 145:4575–4582
81. Genoni G, Prodam F, Marolda A et al (2014) Obesity and infection: two sides of one coin. Eur J Pediatr 173:25–32
82. Giovambattista A, Gaillard RC, Spinedi E (2008) Ghrelin gene-related peptides modulate rat white adiposity. Vitam Horm 77:171–205
83. Gnanapavan S, Kola B, Bustin SA et al (2002) The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans. J Clin Endocrinol Metab 87:2988–2991
84. Goebel-Stengel M, Hofmann T, Elbelt U et al (2013) The ghrelin activating enzyme ghrelin-O-acyltransferase (GOAT) is present in human plasma and expressed dependent on body mass index. Peptides 43:13–19
85. Gonzalez-Gay MA, Garcia-Unzueta MT, Berja A et al (2008) Anti-tumour necrosis factor alpha therapy modulates ghrelin in patients with severe rheumatoid arthritis. Ann Rheum Dis 67:1644–1646
86. Gonzalez-Rey E, Chorny A, Delgado M (2006) Therapeutic action of ghrelin in a mouse model of colitis. Gastroenterology 130:1707–1720
87. Granata R, Settanni F, Biancone L et al (2007) Acylated and unacylated ghrelin promote proliferation and inhibit apoptosis of pancreatic beta-cells and human islets: involvement of 3′,5′-cyclic adenosine monophosphate/protein kinase A, extracellular signal-regulated kinase 1/2, and phosphatidyl inositol 3-kinase/Akt signaling. Endocrinology 148:512–529
88. Granata R, Settanni F, Gallo D et al (2008) Obestatin promotes survival of pancreatic beta-cells and human islets and induces expression of genes involved in the regulation of beta-cell mass and function. Diabetes 57:967–979
89. Granata R, Volante M, Settanni F et al (2010) Unacylated ghrelin and obestatin increase islet cell mass and prevent diabetes in streptozotocin-treated newborn rats. J Mol Endocrinol 45:9–17
90. Granata R, Gallo D, Luque RM et al (2012) Obestatin regulates adipocyte function and protects against diet-induced insulin resistance and inflammation. FASEB J 26:3393–3411
91. Gül FC, Turgut B, Dağlı F et al (2013) The comparison of the impact of ghrelin and tacrolimus on vitreous cytokine levels in an experimental uveitis model. Graefes Arch Clin Exp Ophthalmol 251:1235–1241
92. Guo ZF, Zheng X, Qin YW et al (2007) Circulating preprandial ghrelin to obestatin ratio is increased in human obesity. J Clin Endocrinol Metab 92:1875–1880
93. Guo ZF, Ren AJ, Zheng X et al (2008) Different responses of circulating ghrelin, obestatin levels to fasting, re-feeding and different food compositions, and their local expressions in rats. Peptides 29:1247–1254
94. Gurriarán-Rodríguez U, Al-Massadi O, Roca-Rivada A et al (2011) Obestatin as a regulator of adipocyte metabolism and adipogenesis. J Cell Mol Med 15:1927–1940
95. Gurriarán-Rodríguez U, Santos-Zas I, Al-Massadi O et al (2012) The obestatin/GPR39 system is up-regulated by muscle injury and functions as an autocrine regenerative system. J Biol Chem 287:38379–38389
96. Habegger KM, Grant E, Pfluger PT et al (2011) Ghrelin receptor deficiency does not affect diet-induced atherosclerosis in low-density lipoprotein receptor-null mice. Front Endocrinol 2:67
97. Hattori N, Saito T, Yagyu T et al (2001) GH, GH receptor, GH secretagogue receptor, and ghrelin expression in human T cells, B cells, andneutrophils. J Clin Endocrinol Metab 86:4284–4291
98. Heppner KM, Piechowski CL, Müller A et al (2014) Both acyl and des-acyl ghrelin regulate adiposity and glucose metabolism via central nervous system ghrelin receptors. Diabetes 63:122–131
99. Holdstock C, Ludvigsson J, Karlsson FA (2004) Abnormal ghrelin secretion in new onset childhood Type 1 diabetes. Diabetologia 47:150–151
100. Hosomi S, Oshitani N, Kamata N et al (2008) Phenotypical and functional study of ghrelin and its receptor in the pathogenesis of Crohn’s disease. Inflamm Bowel Dis 14:1205–1213
101. Hou Y, An J, Hu XR et al (2009) Ghrelin inhibits interleukin-8 production induced by hydrogen peroxide in A549 cells via NF-kappaB pathway. Int Immunopharmacol 9:120–126
102. Huml M, Kobr J, Siala K et al (2011) Gut peptide hormones and pediatric type 1 diabetes mellitus. Physiol Res 60:647–658
103. Hwang S, Moon M, Kim S et al (2009) Neuroprotective effect of ghrelin is associated with decreased expression of prostate apoptosis response-4. Endocr J 56:609–617
104. Inhoff T, Mönnikes H, Noetzel S et al (2008) Desacyl ghrelin inhibits the orexigenic effect of peripherally injected ghrelin in rats. Peptides 29:2159–2168
105. Irako T, Akamizu T, Hosoda H et al (2006) Ghrelin prevents development of diabetes at adult age in streptozotocin-treated newborn rats. Diabetologia 49:1264–1273
106. Itoh T, Nagaya N, Yoshikawa M et al (2004) Elevated plasma ghrelin level in underweight patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 170:879–882
107. Jacob A, Rajan D, Pathickal B et al (2010) The inhibitory effect of ghrelin on sepsis-induced inflammation is mediated by the MAPK phosphatase-1. Int J Mol Med 25:159–164
108. Jarocka-Cyrta E, Kasacka I, Kaczmarski M (2010) The ghrelin-positive cells number is increased in duodenum in children with celiac disease. J Endocrinol Invest 33:165–170
109. Jeffery PL, Herington AC, Chopin LK (2002) Expression and action of the growth hormone releasing peptide ghrelin and its receptor in prostate cancer cell lines. J Endocrinol 172:R7–R11
110. Karagiozoglou-Lampoudi T, Trachana M, Agakidis C et al (2011) Ghrelin levels in patients with juvenile idiopathic arthritis: relation to anti-tumor necrosis factor treatment and disease activity. Metabolism 60:1359–1362
111. Karaoglu A, Aydin S, Dagli AF et al (2009) Expression of obestatin and ghrelin in papillary thyroid carcinoma. Mol Cell Biochem 323:113–118
112. Karmiris K, Koutroubakis IE, Xidakis C et al (2006) Circulating levels of leptin, adiponectin, resistin, and ghrelin in inflammatory bowel disease. Inflamm Bowel Dis 12:100–105
113. Katugampola SD, Pallikaros Z, Davenport AP (2001) [125I-His(9)]-ghrelin, a novel radioligand for localizing GHS orphan receptors in human and rat tissue: up-regulation of receptors with athersclerosis. Br J Pharmacol 134:143–149
114. Kellokoski E, Kunnari A, Jokela M et al (2009) Ghrelin and obestatin modulate early atherogenic processes on cells: enhancement of monocyte adhesion and oxidized low-density lipoprotein binding. Metabolism 58:1572–1580
115. Kerem M, Ferahkose Z, Yilmaz UT et al (2008) Adipokines and ghrelin in gastric cancer cachexia. World J Gastroenterol 14:3633–3641
116. Koca SS, Ozgen M, Aydin S et al (2008) Ghrelin and obestatin levels in rheumatoid arthritis. Inflammation 31:329–335
117. Kodama T, Ashitani J, Matsumoto N et al (2008) Ghrelin administration suppressed airway inflammation by decreasing neutrophil accumulation in lungs and increased body weight. Pulm Pharmacol Ther 21:774–779
118. Kojima M, Hosoda H, Date Y et al (1999) Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402:656–660
119. Konturek PC, Brzozowski T, Walter B et al (2006) Ghrelin-induced gastroprotection against ischemia-reperfusion injury involves an activation of sensory afferent nerves and hyperemia mediated by nitric oxide. Eur J Pharmacol 536:171–181
120. Kotani K, Sakane N, Saiga K et al (2006) Serum ghrelin and carotid atherosclerosis in older Japanese people with metabolic syndrome. Arch Med Res 37:903–906
121. Kümpers P, Horn R, Brabant G et al (2008) Serum leptin and ghrelin correlate with disease activity in ANCA-associated vasculitis. Rheumatology 47:484–487
122. Kwan RO, Cureton E, Dozier K et al (2010) Ghrelin decreases microvascular leak during inflammation. J Trauma 68:1186–1191
123. Lacquaniti A, Donato V, Chirico V et al (2011) Obestatin: an interesting but controversial gut hormone. Ann Nutr Metab 59:193–199
124. Lanzini A, Magni P, Petroni ML et al (2006) Circulating ghrelin level is increased in coeliac disease as in functional dyspepsia and reverts to normal during gluten-free diet. Aliment Pharmacol Ther 23:907–913
125. Lauwers E, Landuyt B, Arckens L et al (2006) Obestatin does not activate orphan G protein-coupled receptor GPR39. Biochem Biophys Res Commun 351:21–25
126. Lee S, Kim Y, Li E et al (2012) Ghrelin protects spinal cord motoneurons against chronic glutamate excitotoxicity by inhibiting microglial activation. Korean J Physiol Pharmacol 16:43–48
127. Li WG, Gavrila D, Liu X et al (2004) Ghrelin inhibits proinflammatory responses and nuclear factor-kappaB activation in human endothelial cells. Circulation 109:2221–2226
128. Liu L, Xu H, Jiang H et al (2010) Ghrelin prevents 1-methyl-4-phenylpyridinium ion-induced cytotoxicity through antioxidation and NF-kappaB modulation in MES23.5 cells. Exp Neurol 222:25–29
129. Magiera M, Kopec-Medrek M, Widuchowska M et al (2013) Serum ghrelin in female patients with rheumatoid arthritis during treatment with infliximab. Rheumatol Int 33:1611–1613
130. Martins I, Gomes S, Costa RO et al (2013) Leptin and ghrelin prevent hippocampal dysfunction induced by Aβ oligomers. Neuroscience 241:41–51
131. Martos-Moreno GA, Barrios V, Soriano-Guillén L et al (2006) Relationship between adiponectin levels, acylated ghrelin levels, and short-term body mass index changes in children with diabetes mellitus type 1 at diagnosis and after insulin therapy. Eur J Endocrinol 155:757–761
132. Maruna P, Gürlich R, Frasko R et al (2005) Ghrelin and leptin elevation in postoperative intra-abdominal sepsis. Eur Surg Res 37:354–359
133. Matsumoto M, Hosoda H, Kitajima Y et al (2001) Structure-activity relationship of ghrelin: pharmacological study of ghrelin peptides. Biochem Biophys Res Commun 287:142–146
134. Miegueu P, St Pierre D, Broglio F et al (2011) Effect of desacyl ghrelin, obestatin and related peptides on triglyceride storage, metabolism and GHSR signaling in 3T3-L1 adipocytes. J Cell Biochem 112:704–714
135. Monajemzadeh M, Mokhtari S, Motamed F et al (2013) Plasma ghrelin levels in children with cystic fibrosis and healthy children. Arch Med Sci 9:93–97
136. Moon M, Kim HG, Hwang L et al (2009) Neuroprotective effect of ghrelin in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson’s disease by blocking microglial activation. Neurotox Res 15:332–347
137. Moon M, Choi JG, Nam DW et al (2011) Ghrelin ameliorates cognitive dysfunction and neurodegeneration in intrahippocampal amyloid-β1-42 oligomer-injected mice. J Alzheimers Dis 23:147–159
138. Morillo-Bernal J, Fernández-Santos JM, De Miguel M et al (2011) Ghrelin potentiates TSH-induced expression of the thyroid tissue-specific genes thyroglobulin, thyroperoxidase and sodium-iodine symporter, in rat PC-Cl3 Cells. Peptides 32:2333–2339
139. Muccioli G, Pons N, Ghè C et al (2004) Ghrelin and des-acyl ghrelin both inhibit isoproterenol-induced lipolysis in rat adipocytes via a non-type 1a growth hormone secretagogue receptor. Eur J Pharmacol 498:27–35
140. Murdolo G, Lucidi P, Di Loreto C et al (2003) Insulin is required for prandial ghrelin suppression in humans. Diabetes 52:2923–2927
141. Nagaya N, Uematsu M, Kojima M et al (2001) Elevated circulating level of ghrelin in cachexia associated with chronic heart failure: relationships between ghrelin and anabolic/catabolic factors. Circulation 104:2034–2038
142. Nagaya N, Moriya J, Yasumura Y et al (2004) Effects of ghrelin administration on left ventricular function, exercise capacity, and muscle wasting in patients with chronic heart failure. Circulation 110:3674–3679
143. Nagaya N, Itoh T, Murakami S et al (2005) Treatment of cachexia with ghrelin in patients with COPD. Chest 128:1187–1193
144. Nakahara T, Harada T, Yasuhara D et al (2008) Plasma obestatin concentrations are negatively correlated with body mass index, insulin resistance index, and plasma leptin concentrations in obesity and anorexia nervosa. Biol Psychiatry 64:252–255
145. Neary NM, Small CJ, Wren AM et al (2004) Ghrelin increases energy intake in cancer patients with impaired appetite: acute, randomized, placebo-controlled trial. J Clin Endocrinol Metab 89:2832–2836
146. Pamukcu O, Kumral ZN, Ercan F et al (2013) Anti-inflammatory effect of obestatin and ghrelin in dextran sulfate sodium-induced colitis in rats. J Pediatr Gastroenterol Nutr 57:211–218
147. Patel K, Dixit VD, Lee JH et al (2012a) Identification of ghrelin receptor blocker, D-[Lys3] GHRP-6 as a CXCR4 receptor antagonist. Int J Biol Sci 8:108–117
148. Patel K, Dixit VD, Lee JH et al (2012b) The GHS-R blocker D-[Lys3] GHRP-6 serves as CCR5 chemokine receptor antagonist. Int J Med Sci 9:51–58
149. Peng Z, Zhu Y, Zhang Y et al (2012) Effects of ghrelin on pulmonary NOD2 mRNA expression and NF-κB activation when protects against acute lung injury in rats challenged with cecal ligation and puncture. Int Immunopharmacol 13:440–445
150. Peracchi M, Conte D, Terrani C et al (2003) Circulating ghrelin levels in celiac patients. Am J Gastroenterol 98:2474–2478
151. Porporato PE, Filigheddu N, Reano S et al (2013) Acylated and unacylated ghrelin impair skeletal muscle atrophy in mice. J Clin Invest 123:611–622
152. Portelli J, Michotte Y, Smolders I (2012) Ghrelin: an emerging new anticonvulsant neuropeptide. Epilepsia 53:585–595
153. Pöykkö SM, Kellokoski E, Ukkola O et al (2006) Plasma ghrelin concentrations are positively associated with carotid artery atherosclerosis in males. J Intern Med 260:43–52
154. Prodam F, Bellone S, Corneli G et al (2008) Ghrelin: a molecular target for weight regulation, glucose and lipid metabolism. Recents Patents Endocr Metab Immune Drug Discov 2:172–177
155. Prodam F, Trovato L, Demarchi I et al (2011) Unacylated, acylated ghrelin and obestatin levels are differently inhibited by oral glucose load in pediatric obesity: association with insulin sensitivity and metabolic alterations. Eur J Clin Nutr Metab 6:e109–e115
156. Prodam F, Cadario F, Bellone S et al (2014) Obestatin levels are associated with C-peptide and anti-insulin antibodies at the onset whereas unacylated and acylated ghrelin levels are not predictive of long-term metabolic control in children with type 1 diabetes. J Clin Endocrinol Metab jc20133294
157. Proto C, Romualdi D, Cento RM et al (2006) Plasma levels of neuropeptides in Alzheimer’s disease. Gynecol Endocrinol 22:213–218
158. Pruszynska-Oszmalek E, Szczepankiewicz D, Hertig I et al (2013) Obestatin inhibits lipogenesis and glucose uptake in isolated primary rat adipocytes. J Biol Regul Homeost Agents 27:23–33
159. Raimondo S, Ronchi G, Geuna S et al (2013) Ghrelin: a novel neuromuscular recovery promoting factor? Int Rev Neurobiol 108:207–221
160. Reano S, Graziani A, Filigheddu N (2014) Acylated and unacylated ghrelin administration to blunt muscle wasting. Curr Opin Clin Nutr Metab Care (Epub ahead of print)
161. Reinehr T, de Sousa G, Roth CL (2008) Obestatin and ghrelin levels in obese children and adolescents before and after reduction of overweight. Clin Endocrinol 68:304–310
162. Rey LK, Wieczorek S, Akkad DA et al (2011) Polymorphisms in genes encoding leptin, ghrelin and their receptors in German multiple sclerosis patients. Mol Cell Probes 25:255–259
163. Rezaeian F, Wettstein R, Scheuer C et al (2012) Ghrelin protects musculocutaneous tissue from ischemic necrosis by improving microvascular perfusion. Am J Physiol Heart Circ Physiol 302:H603–H610
164. Rocco A, Sarnelli G, Compare D et al (2008) Tissue ghrelin level and gastric emptying rate in adult patients with celiac disease. Neurogastroenterol Motil 20:884–890
165. Rodríguez A, Gómez-Ambrosi J, Catalán V et al (2012) The ghrelin O-acyltransferase-ghrelin system reduces TNF-α-induced apoptosis and autophagy in human visceral adipocytes. Diabetologia 55:3038–3050
166. Samson WK, White MM, Price C et al (2007) Obestatin acts in brain to inhibit thirst. Am J Physiol Regul Integr Comp Physiol 292:R637–R643
167. Samson WK, Yosten GL, Chang JK et al (2008) Obestatin inhibits vasopressin secretion: evidence for a physiological action in the control of fluid homeostasis. J Endocrinol 196:559–564
168. Sawicka B, Bossowski A, Szalecki M et al (2010) Relationship between metabolic parameters and thyroid hormones and the level of gastric peptides in children with autoimmune thyroid diseases. J Pediatr Endocrinol Metab 23:345–354
169. Schellekens H, McNamara O, Dinan TG et al (2013) Semagacestat, a γ-secretase inhibitor, activates the growth hormone secretagogue (GHSR-1a) receptor. J Pharm Pharmacol 65:528–538
170. Selimoglu MA, Altinkaynak S, Ertekin V et al (2006) Serum ghrelin levels in children with celiac disease. J Clin Gastroenterol 40:191–194
171. Sheriff S, Kadeer N, Joshi R et al (2012) Des-acyl ghrelin exhibits pro-anabolic and anti-catabolic effects on C2C12 myotubes exposed to cytokines and reduces burn-induced muscle proteolysis in rats. Mol Cell Endocrinol 351:286–295
172. Shimizu Y, Nagaya N, Isobe T et al (2003) Increased plasma ghrelin level in lung cancer cachexia. Clin Cancer Res 9:774–778
173. Skilton MR, Nakhla S, Sieveking DP et al (2005) Pathophysiological levels of the obesity related peptides resistin and ghrelin increase adhesion molecule expression on human vascular endothelial cells. Clin Exp Pharmacol Physiol 32:839–844
174. Skurlova M, Stofkova A, Kiss A et al (2010) Transient anorexia, hyper-nociception and cognitive impairment in early adjuvant arthritis in rats. Endocr Regul 44:165–173
175. Slomiany BL, Slomiany A (2013) Involvement of p38 MAPK-dependent activator protein (AP-1) activation in modulation of gastric mucosal inflammatory responses to Helicobacter pylori by ghrelin. Inflammopharmacology 21:67–78
176. Soriano-Guillén L, Barrios V, Lechuga-Sancho A et al (2004) Response of circulating ghrelin levels to insulin therapy in children with newly diagnosed type 1 diabetes mellitus. Pediatr Res 55:830–835
177. Souza-Moreira L, Delgado-Maroto V, Morell M et al (2013) Therapeutic effect of ghrelin in experimental autoimmune encephalomyelitis by inhibiting antigen-specific Th1/Th17 responses and inducing regulatory T cells. Brain Behav Immun 30:54–60
178. Stofkova A, Haluzik M, Zelezna B et al (2009) Enhanced expressions of mRNA for neuropeptide Y and interleukin 1 beta in hypothalamic arcuate nuclei during adjuvant arthritis-induced anorexia in Lewis rats. NeuroImmunoModulation 16:377–384
179. Sung EZ, Da Silva NF, Goodyear S et al (2009) Increased plasma ghrelin following infliximab in Crohn’s disease. Aliment Pharmacol Ther 29:83–89
180. Sung EZ, Da Silva NF, Goodyear SJ et al (2011) Ghrelin promotes nuclear factor kappa-B activation in a human B-lymphocyte cell line. Mol Biol Rep 38:4833–4838
181. Takagi K, Legrand R, Asakawa A et al (2013) Anti-ghrelin immunoglobulins modulate ghrelin stability and its orexigenic effect in obese mice and humans. Nat Commun 4:2685
182. Taub DD (2008) Novel connections between the neuroendocrine and immune systems: the ghrelin immunoregulatory network. Vitam Horm 77:325–346
183. Terashi M, Asakawa A, Harada T et al (2011) Ghrelin reactive autoantibodies in restrictive anorexia nervosa. Nutrition 27:407–413
184. Theil MM, Miyake S, Mizuno M et al (2009) Suppression of experimental autoimmune encephalomyelitis by ghrelin. J Immunol 183:2859–2866
185. Theodoropoulou A, Metallinos IC, Psyrogiannis A et al (2012) Ghrelin and leptin secretion in patients with moderate Alzheimer’s disease. J Nutr Health Aging 16:472–477
186. Togliatto G, Trombetta A, Dentelli P et al (2010) Unacylated ghrelin rescues endothelial progenitor cell function in individuals with type 2 diabetes. Diabetes 59:1016–1025
187. Toshinai K, Yamaguchi H, Sun Y et al (2006) Des-acyl ghrelin induces food intake by a mechanism independent of the growth hormone secretagogue receptor. Endocrinology 147:2306–2314
188. Toussirot E, Mourot L, Dehecq B et al (2013) TNFα blockade for inflammatory rheumatic diseases is associated with a significant gain in android fat mass and has varying effects on adipokines: a 2-year prospective study. Eur J Nutr. doi:10.1007/s00394-013-0599-2
189. Tschöp M, Smiley DL, Heiman ML (2000) Ghrelin induces adiposity in rodents. Nature 407:908–913
190. Turgut B, Gül FC, Dağli F et al (2013) Impact of ghrelin on vitreous cytokine levels in an experimental uveitis model. Drug Des Devel Ther 7:19–24
191. Turk N, Dağistanli FK, Sacan O et al (2012) Obestatin and insulin in pancreas of newborn diabetic rats treated with exogenous ghrelin. Acta Histochem 114:349–357
192. Unger MM, Oertel WH, Tackenberg B (2013) Cerebrospinal fluid concentrations of ghrelin in patients with multiple sclerosis. Neuro Endocrinol Lett 34:14–17
193. Utrilla JC, Morillo-Bernal J, Gordillo-Martínez F et al (2013) Expression of hypothalamic regulatory peptides in thyroid C cells of different mammals. Gen Comp Endocrinol 187:6–14
194. van der Lely AJ, Tschop M, Heiman ML et al (2004) Biological, physiological, pathophysiological, and pharmacological aspects of ghrelin. Endocr Rev 25:426–457
195. van Hagen PM, Dalm VA, Staal F et al (2008) The role of cortistatin in the human immune system. Mol Cell Endocrinol 286:141–147
196. Vicennati V, Genghini S, De Iasio R et al (2007) Circulating obestatin levels and the ghrelin/obestatin ratio in obese women. Eur J Endocrinol 157:295–301
197. Vila G, Maier C, Riedl M et al (2007) Bacterial endotoxin induces biphasic changes in plasma ghrelin in healthy humans. J Clin Endocrinol Metab 92:3930–3934
198. Wang W, Andersson M, Iresjö BM et al (2006) Effects of ghrelin on anorexia in tumor-bearing mice with eicosanoid-related cachexia. Int J Oncol 28:1393–1400
199. Wang W, Bansal S, Falk S et al (2009) Ghrelin protects mice against endotoxemia-induced acute kidney injury. Am J Physiol Renal Physiol 297:F1032–F1037
200. Wang D, Wang H, Luo P et al (2012) Effects of ghrelin on homocysteine-induced dysfunction and inflammatory response in rat cardiac microvascular endothelial cells. Cell Biol Int 36:511–517
201. Waseem T, Duxbury M, Ito H et al (2008) Exogenous ghrelin modulates release of pro-inflammatory and anti-inflammatory cytokines in LPS-stimulated macrophages through distinct signaling pathways. Surgery 143:334–342
202. Wiedmer P, Nogueiras R, Broglio F et al (2007) Ghrelin, obesity and diabetes. Nat Clin Pract Endocrinol Metab 3:705–712
203. Wren AM, Seal LJ, Cohen MA et al (2001) Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab 86:5992
204. Wu R, Dong W, Zhou M et al (2005) Ghrelin improves tissue perfusion in severe sepsis via downregulation of endothelin-1. Cardiovasc Res 68:318–326
205. Wu R, Dong W, Cui X et al (2007a) Ghrelin down-regulates proinflammatory cytokines in sepsis through activation of the vagus nerve. Ann Surg 245:480–486
206. Wu R, Dong W, Zhou M et al (2007b) Ghrelin attenuates sepsis-induced acute lung injury and mortality in rats. Am J Respir Crit Care Med 176:805–813
207. Wu R, Zhou M, Das P et al (2007c) Ghrelin inhibits sympathetic nervous activity in sepsis. Am J Physiol Endocrinol Metab 293:E1697–E1702
208. Wu R, Dong W, Ji Y et al (2008) Orexigenic hormone ghrelin attenuates local and remote organ injury after intestinal ischemia-reperfusion. PLoS ONE 3:e2026
209. Wu R, Dong W, Qiang X et al (2009) Orexigenic hormone ghrelin ameliorates gut barrier dysfunction in sepsis in rats. Crit Care Med 37:2421–2426
210. Wu R, Chaung WW, Dong W et al (2012) Ghrelin maintains the cardiovascular stability in severe sepsis. J Surg Res 178:370–377
211. Yano Y, Toshinai K, Inokuchi T et al (2009) Plasma des-acyl ghrelin, but not plasma HMW adiponectin, is a useful cardiometabolic marker for predicting atherosclerosis in elderly hypertensive patients. Atherosclerosis 204:590–594
212. Yoshimoto A, Mori K, Sugawara A et al (2002) Plasma ghrelin and desacyl ghrelin concentrations in renal failure. J Am Soc Nephrol 13:2748–2752
213. Youm YH, Yang H, Sun Y et al (2009) Deficient ghrelin receptor-mediated signaling compromises thymic stromal cell microenvironment by accelerating thymic adiposity. J Biol Chem 284:7068–7077
214. Yuan MJ, Huang CX, Tang YH et al (2009) A novel peptide ghrelin inhibits neural remodeling after myocardial infarction in rats. Eur J Pharmacol 618:52–57
215. Zhan M, Yuan F, Liu H et al (2008) Inhibition of proliferation and apoptosis of vascular smooth muscle cells by ghrelin. Acta Biochim Biophys Sin 40:769–776
216. Zhang JV, Ren PG, Avsian-Kretchmer O et al (2005) Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin’s effects on food intake. Science 310:996–999
217. Zhao D, Zhan Y, Zeng H et al (2006) Ghrelin stimulates interleukin-8 gene expression through protein kinase C-mediated NF kappaB pathway in human colonic epithelial cells. J Cell Biochem 97:1317–1327
218. Zhou X, Xue C (2009) Ghrelin inhibits the development of acute pancreatitis and nuclear factor kappaB activation in pancreas and liver. Pancreas 38:752–757